Procymate
Clinical data | |
---|---|
Routes of administration | oral |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C10H19O2 |
Molar mass | 185.263 g/mol |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Procymate (Equipax) is a carbamate derivative which is a sedative and anxiolytic drug. It was previously manufactured and marketed in Belgium. The usual dose for adults is 800 to 1200 mg per day.[1] Procymate shares a similar structure and mechanism of action with the related drugs hexapropymate and phenprobamate.
References
- ↑ "Procymate," Bank of Automated Data on Drugs. VIDAL Drug Database. <http://www.biam2.org/www/Sub394.html>
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids | |
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators |
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.